Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Other Non-Current Liabilities (2017 - 2021)

CorMedix (CRMD) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $163403.0 as the latest value for Q4 2021.

Quarterly Other Non-Current Liabilities changed N/A to $163403.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $163403.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $163403.0 for FY2021, N/A changed from the prior year.
Other Non-Current Liabilities hit $163403.0 in Q4 2021 for CorMedix, down from $1.9 million in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $1.9 million in Q2 2017 to a low of $163403.0 in Q4 2021.